Article Details

PharmAust (ASX:PAA) moves to phase three of canine cancer trial

Retrieved on: 2021-06-28 01:30:00

Tags for this article:

Click the tags to see associated articles and topics

PharmAust (ASX:PAA) moves to phase three of canine cancer trial. View article details on hiswai:

Excerpt

Notably, high-grade B-cell lymphoma is one of the more aggressive cancers to be studied in canine oncology. Chief Scientific Officer Dr Richard Mollard ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up